These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33680093)

  • 1. Effects of Lee Silverman Voice Treatment BIG and conventional physiotherapy on non-motor and motor symptoms in Parkinson's disease: a randomized controlled study comparing three exercise models.
    Schaible F; Maier F; Buchwitz TM; Schwartz F; Hoock M; Schönau E; Libuda M; Hordt A; van Eimeren T; Timmermann L; Eggers C
    Ther Adv Neurol Disord; 2021; 14():1756286420986744. PubMed ID: 33680093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lee Silverman Voice Treatment (LSVT)-BIG to improve motor function in people with Parkinson's disease: a systematic review and meta-analysis.
    McDonnell MN; Rischbieth B; Schammer TT; Seaforth C; Shaw AJ; Phillips AC
    Clin Rehabil; 2018 May; 32(5):607-618. PubMed ID: 28980476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing exercise in Parkinson's disease--the Berlin LSVT®BIG study.
    Ebersbach G; Ebersbach A; Edler D; Kaufhold O; Kusch M; Kupsch A; Wissel J
    Mov Disord; 2010 Sep; 25(12):1902-8. PubMed ID: 20669294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Lee Silverman Voice Treatment (LSVT)® BIG on motor symptoms in a patient with severe Parkinson's disease: a case report.
    Hirakawa Y; Takeda K; Koyama S; Naoi Y; Matsushita T; Nagai T; Motoya I; Sakurai H; Kanada Y; Kawamura N; Kawamura M; Tanabe S
    Physiother Theory Pract; 2022 Nov; 38(13):3159-3168. PubMed ID: 34125001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of LSVT BIG intervention to address gait, balance, bed mobility, and dexterity in people with Parkinson disease: a case series.
    Janssens J; Malfroid K; Nyffeler T; Bohlhalter S; Vanbellingen T
    Phys Ther; 2014 Jul; 94(7):1014-23. PubMed ID: 24557655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative clinical assessment of motor function during and following LSVT-BIG® therapy.
    Flood MW; O'Callaghan BPF; Diamond P; Liegey J; Hughes G; Lowery MM
    J Neuroeng Rehabil; 2020 Jul; 17(1):92. PubMed ID: 32660495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of exercise on motor and nonmotor symptoms of Parkinson's disease.
    Dashtipour K; Johnson E; Kani C; Kani K; Hadi E; Ghamsary M; Pezeshkian S; Chen JJ
    Parkinsons Dis; 2015; 2015():586378. PubMed ID: 25722915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of LSVT-BIG via telerehabilitation on non-motor and motor symptoms and quality of life in Parkinson's disease.
    Ekmekyapar Fırat Y; Turgay T; Soğan SS; Günel Karadeniz P
    Acta Neurol Belg; 2023 Feb; 123(1):207-214. PubMed ID: 36175786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term effect and its retention of LSVT® BIG on QOL improvement: 1-year follow-up in a patient with Parkinson's disease.
    Hirakawa Y; Koyama S; Takeda K; Iwai M; Motoya I; Sakurai H; Kanada Y; Kawamura N; Kawamura M; Tanabe S
    NeuroRehabilitation; 2021; 49(3):501-509. PubMed ID: 34180429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Task-Based LSVT-BIG Intervention on Hand Function, Activity of Daily Living, Psychological Function, and Quality of Life in Parkinson's Disease: A Randomized Control Trial.
    Choi Y; Kim D
    Occup Ther Int; 2022; 2022():1700306. PubMed ID: 36133576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect on Gait Speed, Balance, Motor Symptom Rating, and Quality of Life in Those with Stage I Parkinson's Disease Utilizing LSVT BIG®.
    Millage B; Vesey E; Finkelstein M; Anheluk M
    Rehabil Res Pract; 2017; 2017():9871070. PubMed ID: 28331638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicentre, randomised controlled trial to compare the clinical and cost-effectiveness of Lee Silverman Voice Treatment versus standard NHS Speech and Language Therapy versus control in Parkinson's disease: a study protocol for a randomised controlled trial.
    Sackley CM; Rick C; Au P; Brady MC; Beaton G; Burton C; Caulfield M; Dickson S; Dowling F; Hughes M; Ives N; Jowett S; Masterson-Algar P; Nicoll A; Patel S; Smith CH; Woolley R; Clarke CE;
    Trials; 2020 May; 21(1):436. PubMed ID: 32460885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occupational Performance and Hand Function in People With Parkinson's Disease After Participation in Lee Silverman Voice Treatment (LSVT) BIG®.
    Doucet BM; Blanchard M; Bienvenu F
    Am J Occup Ther; 2021 Nov; 75(6):. PubMed ID: 34817592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lee Silverman Voice Treatment to Improve Speech in Parkinson's Disease: A Systemic Review and Meta-Analysis.
    Pu T; Huang M; Kong X; Wang M; Chen X; Feng X; Wei C; Weng X; Xu F
    Parkinsons Dis; 2021; 2021():3366870. PubMed ID: 35070257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LSVT-BIG therapy in Parkinson's disease: physiological evidence for proprioceptive recalibration.
    Peterka M; Odorfer T; Schwab M; Volkmann J; Zeller D
    BMC Neurol; 2020 Jul; 20(1):276. PubMed ID: 32652957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of rotigotine transdermal patch in patients with Parkinson's disease presenting with non-motor symptoms - results of a double-blind, randomized, placebo-controlled trial.
    Antonini A; Bauer L; Dohin E; Oertel WH; Rascol O; Reichmann H; Schmid M; Singh P; Tolosa E; Chaudhuri KR
    Eur J Neurol; 2015 Oct; 22(10):1400-7. PubMed ID: 26095948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of an extended version of the lee silverman voice treatment on voice and speech in Parkinson's disease.
    Spielman J; Ramig LO; Mahler L; Halpern A; Gavin WJ
    Am J Speech Lang Pathol; 2007 May; 16(2):95-107. PubMed ID: 17456888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lee Silverman voice treatment (LSVT) mitigates voice difficulties in mild Parkinson's disease.
    Saffarian A; Amiri Shavaki Y; Shahidi GA; Hadavi S; Jafari Z
    Med J Islam Repub Iran; 2019; 33():5. PubMed ID: 31086784
    [No Abstract]   [Full Text] [Related]  

  • 19. Non-Motor Symptoms as Predictors of Quality of Life in Egyptian Patients With Parkinson's Disease: A Cross-Sectional Study Using a Culturally Adapted 39-Item Parkinson's Disease Questionnaire.
    Shalash AS; Hamid E; Elrassas HH; Bedair AS; Abushouk AI; Khamis M; Hashim M; Ahmed NS; Ashour S; Elbalkimy M
    Front Neurol; 2018; 9():357. PubMed ID: 29881368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of Lee Silverman Voice Treatment® LOUD on Japanese-Speaking Patients with Parkinson's Disease.
    Nakayama K; Yamamoto T; Oda C; Sato M; Murakami T; Horiguchi S
    Rehabil Res Pract; 2020; 2020():6585264. PubMed ID: 32411475
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.